Background/aims Amongst numerous travellers to high altitude (HA) are many with the
highly prevalent COPD, who are at particular risk for altitude-related adverse health effects …

Background: There are no reliable means to identify patients with COPD at risk of altitude-
related adverse health effects (ARAHE) during altitude travel. Therefore, diagnostic tests that …

Background Risk prediction of acute mountain sickness, high altitude (HA) pulmonary or
cerebral edema is currently based on clinical assessment. Our objective was to develop a …

The reduced pressure in an aircraft cabin may cause significant hypoxaemia and respiratory
symptoms in patients with chronic obstructive pulmonary disease (COPD). The current study …

Background Patients with chronic pulmonary diseases are at increased risk of hypoxemia
when traveling by air. Screening guidelines, predictive equations based on ground level …

Background We evaluated the efficacy of acetazolamide in preventing adverse altitude
effects in patients with moderate to severe chronic obstructive pulmonary disease (COPD) …

Altitude travelers are exposed to high-altitude pathologies, which can be potentially serious.
Individual susceptibility varies widely and this makes it difficult to predict who will develop …

Bloch, Konrad E., Talant M. Sooronbaev, Silvia Ulrich, Mona Lichtblau, and Michael Furian.
Clinician's corner: counseling patients with chronic obstructive pulmonary disease traveling …

Background Amongst the millions of travelers to high altitude worldwide are many with
chronic obstructive pulmonary disease (COPD), but data regarding the effects of acute …

Background COPD may predispose to symptomatic pulmonary hypertension at high altitude.
We investigated haemodynamic changes in lowlanders with COPD ascending to 3100 m …